...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >A study on management of hypertension in patients with type 2 diabetes mellitus in tertiary care teaching rural hospital
【24h】

A study on management of hypertension in patients with type 2 diabetes mellitus in tertiary care teaching rural hospital

机译:三级教学农村医院二型糖尿病患者高血压的管理研究

获取原文
           

摘要

Background: This study was aimed to analyze the drug utilization pattern in the management of hypertension in diabetic patients. Methods: A prospective, observational and non interventional study was conducted in 100 diabetic hypertensive patients admitted in medicine wards at Dhiraj Hospital. Patients who signed informed consent form were only included in the study. All the data were recorded from patients’ case files and analyzed. Results: Of enrolled 100 patients, 69 (69%) were male and 31 (31%) were female and maximum number of the patients (42%) were found in the age group of 51-60 years. Out of 100 admitted patients, 75% patients were treated with single antihypertensive agent, 20% were treated with combination of two antihypertensive agents while only 5% were administered more than two antihypertensive agents. As a single antihypertensive agent, most commonly prescribed was ACE inhibitors (32%), Calcium Channel Blockers (23%), Angiotensin Receptor Blockers (12%) and β1 blockers (8%). Conclusions: There was poor awareness among the patients regarding control of hypertension, regular follow up, medication adherence etc. However, two third of diabetic patients had achieved blood pressure target control and ACE inhibitor remained first choice of drug for hypertension in diabetes in this study.
机译:背景:本研究旨在分析糖尿病患者高血压管理中的药物利用模式。方法:在Dhiraj医院的病房中对100名糖尿病高血压患者进行了一项前瞻性,观察性和非干预性研究。签署知情同意书的患者仅纳入研究。所有数据均从患者的病例档案中记录并进行了分析。结果:在入组的100名患者中,男性为69名(69%),女性为31名(31%),最大年龄段的患者(42%)位于51-60岁年龄段。在100名入院患者中,有75%的患者接受了单一降压药治疗,有20%的患者接受了两种降压药联合治疗,而只有5%的患者接受了两种以上的降压药治疗。作为单一的降压药,最常用的是ACE抑制剂(32%),钙通道阻滞剂(23%),血管紧张素受体阻滞剂(12%)和β1阻滞剂(8%)。结论:患者对高血压的控制,定期随访,依从性等方面的认识较差。但是,本研究中有三分之二的糖尿病患者已达到控制血压的目标,而ACE抑制剂仍然是糖尿病高血压的首选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号